CDP runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impact. In 2023, more than 23,000 companies disclosed their climate, forests and water security impacts through CDP. WuXi Biologics, with its effective implementation of current best practices, received a Leadership-level "A-" score for climate change, significantly higher than the average "C" score of both its sector and the Asia region.

Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, "We are very pleased to be recognized by CDP for our proactive efforts to tackle climate change. Disclosure is an essential first step, not the destination. With an unwavering commitment to improving environmental performance, WuXi Biologics will continue to lead the way in environmental management and transparency with tangible actions, enabling our global partners and creating positive impacts for the whole community."

In 2023, WuXi Biologics saw fruitful progress in tackling climate change. From its Climate Change Policy upgrade to an Energy Saving Whitepaper release, the company has taken substantial measures to reduce its impacts on the environment. It also signed the Science Based Targets initiative's (SBTi) commitment letter, marking a new milestone in its Net-Zero journey. Going forward, the company will develop science-based carbon targets and emission-reduction roadmaps in accordance with SBTi, further advancing global sustainability.

WuXi Biologics has been recognized by a number of global rating agencies over the past year, including being named to the S&P Dow Jones Sustainability™ World Index, and receiving an MSCI AAA Rating and an EcoVadis Platinum Medal.